<description>&lt;p&gt;Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer. &lt;/p&gt;&lt;p&gt;CME information and select publications &lt;a href="http://m.researchtopractice.com/OncologyTodayPARPProstate26" rel="noopener noreferrer" target="_blank"&gt;here&lt;/a&gt;. &lt;/p&gt;</description>

Oncology Today with Dr Neil Love

Research To Practice

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

MAY 15, 202651 MIN
Oncology Today with Dr Neil Love

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

MAY 15, 202651 MIN

Description

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer. CME information and select publications here.